Royce & Associates LP Buys New Shares in Paysign, Inc. (NASDAQ:PAYS)

Royce & Associates LP purchased a new position in Paysign, Inc. (NASDAQ:PAYS) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 221,711 shares of the company’s stock, valued at approximately $814,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Joule Financial LLC purchased a new stake in Paysign in the third quarter valued at approximately $1,478,000. Renaissance Technologies LLC boosted its holdings in shares of Paysign by 25.0% in the 2nd quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock valued at $6,484,000 after purchasing an additional 301,000 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of Paysign during the 2nd quarter valued at $512,000. Vanguard Group Inc. increased its holdings in shares of Paysign by 3.0% during the 1st quarter. Vanguard Group Inc. now owns 1,649,043 shares of the company’s stock worth $6,035,000 after buying an additional 48,489 shares during the last quarter. Finally, Quadrature Capital Ltd purchased a new position in shares of Paysign in the 1st quarter worth $147,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Barrington Research reissued an “outperform” rating and set a $7.00 price target on shares of Paysign in a research report on Monday, November 4th.

Paysign Stock Up 2.7 %

Shares of PAYS stock opened at $3.39 on Thursday. Paysign, Inc. has a fifty-two week low of $2.22 and a fifty-two week high of $5.59. The firm’s 50 day moving average price is $3.87 and its two-hundred day moving average price is $4.30. The stock has a market cap of $181.53 million, a price-to-earnings ratio of 22.60 and a beta of 0.95.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The firm had revenue of $15.26 million during the quarter, compared to analysts’ expectations of $14.96 million. During the same period in the prior year, the company earned $0.02 EPS. On average, equities analysts forecast that Paysign, Inc. will post 0.21 EPS for the current fiscal year.

Insider Activity

In related news, CEO Mark Newcomer sold 25,000 shares of Paysign stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $3.27, for a total transaction of $81,750.00. Following the sale, the chief executive officer now owns 9,236,886 shares of the company’s stock, valued at $30,204,617.22. The trade was a 0.27 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Matthew Louis Lanford sold 25,360 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $3.96, for a total transaction of $100,425.60. Following the completion of the transaction, the insider now directly owns 109,731 shares of the company’s stock, valued at approximately $434,534.76. The trade was a 18.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 301,360 shares of company stock worth $1,112,036. 23.30% of the stock is currently owned by corporate insiders.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.